Antibacterial activities of new nitrofuran derivatives on Mycoplasm gallisepticum and Haemophilus gallinarum.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D002645:Chickens; D002701:Chloramphenicol / Q000494:pharmacology; D004096:Dihydrostreptomycin Sulfate / Q000494:pharmacology; D005664:Furazolidone / Q000494:pharmacology; D006190:Haemophilus / Q000187:drug effects*; D006192:Haemophilus Infections / Q000188:drug therapy; D006385:Hemagglutination Inhibition Tests; D007933:Leucomycins / Q000494:pharmacology; D009174:Mycoplasma / Q000187:drug effects*; D009175:Mycoplasma Infections / Q000188:drug therapy; D009581:Nitrofurans / Q000494:pharmacology* / Q000627:therapeutic use; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D007933:Leucomycins; D009581:Nitrofurans; D005664:Furazolidone; D002701:Chloramphenicol; D013752:Tetracycline; D004096:Dihydrostreptomycin Sulfate